← FDA Drug Approvals (Drugs@FDA)
NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: COREPHARMA · Approved 2019-08-22
Drug application
- FDA Application #
ANDA211830- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE
- Generic name
- Diphenhydramine Hydrochloride
- Active ingredients
- DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Over-the-counter
- Sponsor
- COREPHARMA
- First approval
- 2019-08-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown